AAP
VMD icon

Arax Advisory Partners’s Viemed Healthcare VMD Stock Holding History

Arax Advisory Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276 Buy
+30
New +$250 ﹤0.01% 3503
2025
Q4 		– Sell
-861
Closed -$5.85K – 4553
2025
Q3 		$5.85K Buy
+861
New +$5.83K ﹤0.01% 2817
2025
Q1 		– Sell
-47
Closed -$377 – 3060
2024
Q4 		$377 Sell
47
-26
-36% -$226 ﹤0.01% 2348
2024
Q3 		$536 Hold
73
– – ﹤0.01% 2392
2024
Q2 		$479 Buy
+73
New +$550 ﹤0.01% 2338

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Arax Advisory Partners's VMD Position: Q1 2026 in Review

Arax Advisory Partners opened a new position in Viemed Healthcare (VMD) in Q1 2026: 30 shares worth $276. The stake represents ﹤0.01% of the portfolio and ranks #3503 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in VMD as recently as Q3 2025.

Arax Advisory Partners first reported a position in VMD in Q2 2024 and has held it in 5 quarters since. The position peaked at $5.85K in Q3 2025. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Arax Advisory Partners held 30 shares of Viemed Healthcare worth $276 as of Q1 2026.
  • Viemed Healthcare was a new Arax Advisory Partners position in Q1 2026.
  • Viemed Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3503 holding.
  • Arax Advisory Partners first reported a position in Viemed Healthcare in Q2 2024 and has held it in 5 quarters since.
  • Arax Advisory Partners's Viemed Healthcare position peaked at $5.85K in Q3 2025.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.